Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Filspari
Filspari
Travere cuts workforce by 20% as Filspari's prospects are up in one rare kidney disease, down in another
Fierce Pharma
Tue, 12/5/23 - 11:58 pm
Travere Therapeutics
Filspari
layoffs
Travere Touts Phase III Kidney Disease Data for Filspari After Trial Failures
BioSpace
Mon, 11/6/23 - 09:57 am
Travere Therapeutics
kidney disease
Filspari
clinical trials
As trial miss threatens FDA approval, Travere points to Filspari's benefits in bid to stay in kidney disease
Fierce Pharma
Fri, 11/3/23 - 10:53 am
Travere Therapeutics
Filspari
IgA nephropathy
kidney disease
FDA
Travere’s Kidney Disease Drug Narrowly Misses Phase III Endpoint, Stock Tanks
BioSpace
Thu, 09/21/23 - 06:34 pm
Travere Therapeutics
kidney disease
sparsentan
Filspari
clinical trials
Travere trips up but others are following in rare kidney disease
EP Vantage
Fri, 05/5/23 - 10:07 am
Travere Therapeutics
Filspari
focal segmental glomerulosclerosis
Travere’s Filspari reduces urine protein levels in adults with IgAN
Clinical Trials Arena
Mon, 04/3/23 - 09:50 am
Travere Therapeutics
Filspari
IgA nephropathy
clinical trials